Literature DB >> 18030205

Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.

Michael K Davis1, Joel M Andres, Christopher D Jolley, Donald A Novak, Allah B Haafiz, Regino P González-Peralta.   

Abstract

OBJECTIVES: Antibodies to Escherichia coli outer membrane porin C (anti-OmpC), Saccharomyces cerevisiae, and neutrophil-specific nuclear antigens are associated with inflammatory bowel disease (IBD) in children and young adults. We hypothesized that anti-OmpC, in the absence of anti-S cerevisiae antibodies (ASCA) and antineutrophil cytoplasmic antibodies (ANCA), is an assay that overestimates the presence of Crohn disease (CD) and ulcerative colitis (UC). PATIENTS AND METHODS: A retrospective review of patients evaluated at our institution between January 2002 and June 2006 revealed that 170 had serodiagnostic immunological assays performed as part of an evaluation for possible IBD. The assays were screened for a pattern in which anti-OmpC was present in the absence of ASCA and ANCA.
RESULTS: Seven patients between 3 and 20 years of age were discovered to be positive for anti-OmpC but negative for ASCA and ANCA. These patients were determined to have significant medical conditions without combined radiographic, endoscopic, or histological evidence of IBD. Despite the reported 85% positive predictive value of anti-OmpC for IBD, none of the 7 patients with isolated anti-OmpC had a diagnosis of CD or UC.
CONCLUSIONS: Anti-OmpC, in the absence of ASCA and ANCA, is a serological pattern noted in a subset of medically complex cases in children and young adults without CD or UC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030205     DOI: 10.1097/MPG.0b013e31812f7f6e

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

Review 1.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

Review 2.  New serological markers in pediatric patients with inflammatory bowel disease.

Authors:  Márta Kovács; Katalin Eszter Müller; Mária Papp; Péter László Lakatos; Mihály Csöndes; Gábor Veres
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 3.  Diagnostic advances in inflammatory bowel disease (imaging and laboratory).

Authors:  Maria E Moscandrew; Edward V Loftus
Journal:  Curr Gastroenterol Rep       Date:  2009-12

4.  Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation.

Authors:  Anupa Kamat; Petronela Ancuta; Richard S Blumberg; Dana Gabuzda
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

5.  Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis.

Authors:  Siddharth P Sura; Awais Ahmed; Adam S Cheifetz; Alan C Moss
Journal:  J Clin Gastroenterol       Date:  2014-04       Impact factor: 3.062

6.  Autoimmunity and the microbiome: T-cell receptor mimicry of "self" and microbial antigens mediates self tolerance in holobionts: The concepts of "holoimmunity" (TcR-mediated tolerance for the holobiont) and "holoautoimmunity" (loss of tolerance for the holobiont) are introduced.

Authors:  Robert Root-Bernstein
Journal:  Bioessays       Date:  2016-09-05       Impact factor: 4.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.